Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1984 2
1988 4
1990 2
1992 2
1993 1
1994 2
1995 3
1996 3
1997 5
1998 2
1999 1
2000 3
2001 5
2002 3
2003 5
2004 8
2005 9
2006 12
2007 8
2008 3
2009 10
2010 11
2011 14
2012 13
2013 19
2014 12
2015 21
2016 31
2017 32
2018 49
2019 74
2020 113
2021 117
2022 132
2023 124
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

786 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
Burstein S. Burstein S. Bioorg Med Chem. 2015 Apr 1;23(7):1377-85. doi: 10.1016/j.bmc.2015.01.059. Epub 2015 Feb 7. Bioorg Med Chem. 2015. PMID: 25703248 Review.
This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must be seen as unfortunate since a number of actions of CBD with potential therapeutic benefit were downplayed for many years. In …
This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must …
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
White CM. White CM. J Clin Pharmacol. 2019 Jul;59(7):923-934. doi: 10.1002/jcph.1387. Epub 2019 Feb 7. J Clin Pharmacol. 2019. PMID: 30730563 Review.
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...The control of refractory seizures is a clear exception, with strong evidence of CBD's benefit. Acute CBD dosing before anxiety-provoking events like publ …
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...The control of refractory seizures …
Cannabidiol Adverse Effects and Toxicity.
Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardò FP. Huestis MA, et al. Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901. Curr Neuropharmacol. 2019. PMID: 31161980 Free PMC article. Review.
Studies defining CBD's beneficial effects were included to provide balance in estimating risk/benefit. ...Human CBD studies for epilepsy and psychiatric disorders reported CBD-induced drug-drug interactions, hepatic abnormalities, diarrhea, fatigue, vo …
Studies defining CBD's beneficial effects were included to provide balance in estimating risk/benefit. ...Human CBD stu …
The Trouble with CBD Oil.
Hazekamp A. Hazekamp A. Med Cannabis Cannabinoids. 2018 Jun 12;1(1):65-72. doi: 10.1159/000489287. eCollection 2018 Jun. Med Cannabis Cannabinoids. 2018. PMID: 34676324 Free PMC article.
The cannabinoid CBD, a non-psychoactive isomer of the more infamous tetrahydrocannabinol (THC), is available in a growing number of administration modes, but the most commonly known is CBD oil. ...The intention of this paper is to create a better understanding of th …
The cannabinoid CBD, a non-psychoactive isomer of the more infamous tetrahydrocannabinol (THC), is available in a growing number of a …
Cannabidiol: pharmacology and therapeutic targets.
Britch SC, Babalonis S, Walsh SL. Britch SC, et al. Psychopharmacology (Berl). 2021 Jan;238(1):9-28. doi: 10.1007/s00213-020-05712-8. Epub 2020 Nov 21. Psychopharmacology (Berl). 2021. PMID: 33221931 Free PMC article. Review.
RATIONALE: Cannabidiol (CBD) products lacking regulatory approval are being used to self-treat a myriad of conditions and for their unsubstantiated health benefits. ...Although Epidiolex is safe for human consumption, recent changes in regulation of commercially ava …
RATIONALE: Cannabidiol (CBD) products lacking regulatory approval are being used to self-treat a myriad of conditions and for their u …
Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders.
Baswan SM, Klosner AE, Glynn K, Rajgopal A, Malik K, Yim S, Stern N. Baswan SM, et al. Clin Cosmet Investig Dermatol. 2020 Dec 8;13:927-942. doi: 10.2147/CCID.S286411. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 33335413 Free PMC article. Review.
Though there is limited research confirming the purported topical benefits of cannabinoids, it is certain that cutaneous biology is modulated by the human endocannabinoid system (ECS). ...This article provides an update on the advances in CBD research to date and th …
Though there is limited research confirming the purported topical benefits of cannabinoids, it is certain that cutaneous biology is m …
The pharmacokinetics and the pharmacodynamics of cannabinoids.
Lucas CJ, Galettis P, Schneider J. Lucas CJ, et al. Br J Clin Pharmacol. 2018 Nov;84(11):2477-2482. doi: 10.1111/bcp.13710. Epub 2018 Aug 7. Br J Clin Pharmacol. 2018. PMID: 30001569 Free PMC article. Review.
An important example is the CBD-mediated inhibition of clobazam metabolism. Pharmacodynamic interactions may occur if cannabis is administered with other central nervous system depressant drugs, and cardiac toxicity may occur via additive hypertension and tachycardia with …
An important example is the CBD-mediated inhibition of clobazam metabolism. Pharmacodynamic interactions may occur if cannabis is adm …
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
García-Gutiérrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. García-Gutiérrez MS, et al. Biomolecules. 2020 Nov 19;10(11):1575. doi: 10.3390/biom10111575. Biomolecules. 2020. PMID: 33228239 Free PMC article. Review.
Numerous studies have been carried out using the main phytocannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). CBD displays an interesting pharmacological profile without the potential for becoming a drug of abuse, unlike THC. ...Preliminary clinical tri …
Numerous studies have been carried out using the main phytocannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). CBD …
The Pharmacological Case for Cannabigerol.
Nachnani R, Raup-Konsavage WM, Vrana KE. Nachnani R, et al. J Pharmacol Exp Ther. 2021 Feb;376(2):204-212. doi: 10.1124/jpet.120.000340. Epub 2020 Nov 9. J Pharmacol Exp Ther. 2021. PMID: 33168643 Review.
Medical cannabis and individual cannabinoids, such as delta9-tetrahydrocannabinol (delta9-THC) and cannabidiol (CBD), are receiving growing attention in both the media and the scientific literature. ...SIGNIFICANCE STATEMENT: Cannabigerol is currently being marketed as a d …
Medical cannabis and individual cannabinoids, such as delta9-tetrahydrocannabinol (delta9-THC) and cannabidiol (CBD), are receiving g …
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.
Watt G, Karl T. Watt G, et al. Front Pharmacol. 2017 Feb 3;8:20. doi: 10.3389/fphar.2017.00020. eCollection 2017. Front Pharmacol. 2017. PMID: 28217094 Free PMC article. Review.
Interestingly, combination therapies of CBD and delta(9)-tetrahydrocannabinol (THC), the main active ingredient of cannabis sativa, show that CBD can antagonize the psychoactive effects associated with THC and possibly mediate greater therapeutic benefits tha …
Interestingly, combination therapies of CBD and delta(9)-tetrahydrocannabinol (THC), the main active ingredient of cannabis sativa, s …
786 results